Thermo Fisher Scientific Inc
NYSE:TMO
Intrinsic Value
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. [ Read More ]
The intrinsic value of one
TMO
stock under the Base Case scenario is
465.3
USD.
Compared to the current market price of 539.58 USD,
Thermo Fisher Scientific Inc
is
Overvalued by 14%.
Thermo Fisher Scientific Inc's market capitalization is 208.6B USD.
TMO stock price is 539.58 USD.
TMO stock (465.3 USD) is 14% less than its price (539.58 USD).
TMO stock price (539.58 USD) is 15% less than its Relative Value (637.74 USD). Open Relative Valuation
TMO has upside potential of 14% compared to the average analyst price target.
Open Wall St Estimates
TMO's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 8%.
TMO's ROE (Return on Equity) for the past 12 months is positive and is equal to 13%.
TMO's Revenue has dropped by 5% over the past 12 months.
TMO's Revenue is forecast to grow at a rate of 5% per year over the next 3 years.
TMO has positive three-year average ROIC (Return on Invested Capital): 12%. The company is efficient at using invested capital to generate operating income.
TMO's ROIC (Return on Invested Capital) has decreased in the last 3 years from 15% to 8%.
TMO has positive Net Income for the last twelve months.
TMO's Revenue has been growing by 10% per year for the last 3 years.
TMO's ROE (Return on Equity) has significantly decreased in the last 3 years from 25% to 13%.
TMO has positive Operating Income for the last twelve months.
TMO has positive three-year average ROE (Return on Equity): 19%. The company is efficient at transforming stockholders' equity into net income.
TMO's short-term assets (25B USD) exceed its short-term liabilties (14B USD).
TMO's long-term assets (99B USD) exceed its long-term liabilties (52B USD).
TMO's D/E (Debt to Equity) is very low and is equal to 0.67.
TMO has positive Free Cash Flow for the last twelve months.
TMO has positive Gross Profit for the last twelve months.
TMO has positive Net Debt. This means that the company has more debt (31B USD) than cash and short-term investments (8B USD).
TMO's Altman Z-Score is very high and is equal to 3.75.
TMO generates enough operating income (7B USD) to cover interest payments on its debt (1B USD).
Valuation Backtest
Thermo Fisher Scientific Inc
Run backtest to discover the historical profit from buying and selling
TMO
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Thermo Fisher Scientific Inc
Balance Sheet Decomposition
Thermo Fisher Scientific Inc
| Current Assets | 24.6B |
| Cash & Short-Term Investments | 8.1B |
| Receivables | 9.7B |
| Other Current Assets | 6.8B |
| Non-Current Assets | 74.1B |
| PP&E | 11B |
| Intangibles | 60.7B |
| Other Non-Current Assets | 2.4B |
| Current Liabilities | 14B |
| Accounts Payable | 2.9B |
| Accrued Liabilities | 4.8B |
| Other Current Liabilities | 6.3B |
| Non-Current Liabilities | 38B |
| Long-Term Debt | 31.3B |
| Other Non-Current Liabilities | 6.7B |
Earnings Waterfall
Thermo Fisher Scientific Inc
|
Revenue
|
42.9B
USD
|
|
Cost of Revenue
|
-25.8B
USD
|
|
Gross Profit
|
17.1B
USD
|
|
Operating Expenses
|
-9.8B
USD
|
|
Operating Income
|
7.3B
USD
|
|
Other Expenses
|
-1.3B
USD
|
|
Net Income
|
6B
USD
|
Free Cash Flow Analysis
Thermo Fisher Scientific Inc
What is Free Cash Flow?
TMO Profitability Score
Profitability Due Diligence
Thermo Fisher Scientific Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Thermo Fisher Scientific Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
TMO Solvency Score
Solvency Due Diligence
Thermo Fisher Scientific Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Thermo Fisher Scientific Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TMO Price Targets Summary
Thermo Fisher Scientific Inc
According to Wall Street analysts, the average 1-year price target for
TMO
is 617.54 USD
with a low forecast of 525.2 USD and a high forecast of 689.85 USD.
Ownership
TMO Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
TMO Price
Thermo Fisher Scientific Inc
| Average Annual Return | 23.43% |
| Standard Deviation of Annual Returns | 26.17% |
| Max Drawdown | -35% |
| Market Capitalization | 211.6B USD |
| Shares Outstanding | 381 713 984 |
| Percentage of Shares Shorted | 0.68% |
TMO News
Last Important Events
Thermo Fisher Scientific Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Thermo Fisher Scientific Inc
Company Profile
Thermo Fisher Scientific Inc
Country
Industry
Market Cap
Dividend Yield
Description
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. The company is headquartered in Waltham, Massachusetts and currently employs 130,000 full-time employees. The firm segments include Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The firm offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines. Analytical Instruments segment provides a broad offering of instruments, consumables, software and services that are used for applications in the laboratory. Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Services segment offers products and solutions needed for the laboratory.
Contact
IPO
Employees
Officers
The intrinsic value of one
TMO
stock under the Base Case scenario is
465.3
USD.
Compared to the current market price of 539.58 USD,
Thermo Fisher Scientific Inc
is
Overvalued by 14%.
You don't have any saved screeners yet
